Xagenic was a molecular diagnostics company based in Toronto, Canada. The company was developing a fully automated platform designed to deliver lab-quality results in 20 minutes, enabling rapid, on-demand testing at the point of care. Their proprietary technology utilized nanostructured microelectrodes for direct detection of nucleic acids without the need for sample extraction or enzymes.
Diagnostics
CTI LSF I
Co-Lead
Director
January 24, 2012
Liquidated in 2018
Series A
Xagenics had the potential to decentralize molecular diagnostics, enabling clinicians to make immediate treatment decisions during patient consultations
